Cargando…

Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication

BACKGROUND: Flares of juvenile idiopathic arthritis (JIA) have been described in the context of various infections. Flares of rheumatic diseases in adults have been described following infection with SARS-CoV-2 in several cohorts. So far, the effect of infection with SARS-CoV-2 on the course of JIA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hügle, Boris, Krumrey-Langkammerer, Manuela, Haas, Johannes-Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628278/ https://www.ncbi.nlm.nih.gov/pubmed/34844609 http://dx.doi.org/10.1186/s12969-021-00653-8

Ejemplares similares

PReS-FINAL-2030: Treatment with leflunomide results in a higher flare rate of chronic uveitis compared to methotrexate in patients with juvenile idiopathic arthritis treated with both drugs
por: Bichler, J, et al.
Publicado: (2013)

Salivary gland ultrasound in the diagnostic workup of juvenile Sjögren’s syndrome and mixed connective tissue disease
por: Krumrey-Langkammerer, Manuela, et al.
Publicado: (2020)

IL-6 blockade in systemic juvenile idiopathic arthritis – achievement of inactive disease and remission (data from the German AID-registry)
por: Bielak, M., et al.
Publicado: (2018)

Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis
por: Hügle, Boris, et al.
Publicado: (2017)

Treatment preferences in juvenile idiopathic arthritis – a comparative analysis in two health care systems
por: Hugle, Boris, et al.
Publicado: (2013)

Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
por: Scheuern, Andrea, et al.
Publicado: (2016)

α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis
por: Zeller, Ludwig, et al.
Publicado: (2022)

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
por: Schiappapietra, B, et al.
Publicado: (2011)

Education and employment in patients with juvenile idiopathic arthritis – a standardized comparison to the German general population
por: Schlichtiger, Jenny, et al.
Publicado: (2017)

Genomic characterization of remission in juvenile idiopathic arthritis
por: Jiang, Kaiyu, et al.
Publicado: (2013)

Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course
por: Hügle, Boris, et al.
Publicado: (2014)

Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case–control study
por: Barth, Swaantje, et al.
Publicado: (2016)

Treatment preferences in juvenile idiopathic arthritis – a comparative analysis in two health care systems
por: Hugle, Boris, et al.
Publicado: (2011)

Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population
por: Barth, Swaantje, et al.
Publicado: (2016)

Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
por: Höfel, Lea, et al.
Publicado: (2018)

MRI evaluation of clinical remission in juvenile idiopathic arthritis
por: van Veenendaal, M, et al.
Publicado: (2011)

Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients
por: Holzer, Marie-Therese, et al.
Publicado: (2022)

PReS-FINAL-2152: Biomarkers as predictors of early inactive disease in children with juvenile idiopathic arthritis
por: Lavric, M, et al.
Publicado: (2013)

Impaired Muscular Fat Metabolism in Juvenile Idiopathic Arthritis in Inactive Disease
por: Rochette, Emmanuelle, et al.
Publicado: (2019)

AZD-1222: Flares of systemic onset juvenile idiopathic arthritis: case report
Publicado: (2022)

Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent
por: Woerner, A, et al.
Publicado: (2015)

Clinical remission in juvenile idiopathic arthritis after termination of etanercept
por: Postępski, Jacek, et al.
Publicado: (2012)

Inactive disease and remission rates after intraarticular steroids as initial therapy for juvenile idiopathic arhtritis (JIA)
por: Sato, JO, et al.
Publicado: (2011)

PReS-FINAL-2031: Hyaluronic acid is a marker of active arthritis, but not systemic inflammation in systemic juvenile idiopathic arthritis
por: Hugle, B, et al.
Publicado: (2013)

Discontinuation of etanercept after clinical remission in patients with juvenile idiopathic arthritis
por: Cohen, Jean-David, et al.
Publicado: (2012)

How common is remission in juvenile idiopathic arthritis: A systematic review
por: Shoop-Worrall, Stephanie J.W., et al.
Publicado: (2017)

Patients with juvenile idiopathic arthritis in clinical remission with positive power Doppler signal in joint ultrasonography have an increased rate of clinical flare: a prospective study
por: Miotto e Silva, Vanessa Bugni, et al.
Publicado: (2017)

The risk and nature of flares in juvenile idiopathic arthritis: results from the reACCh-Out cohort
por: Guzman, Jaime, et al.
Publicado: (2014)

Blood calprotectin in children with juvenile idiopathic arthritis: relationship to flare development after discontinuation of treatment
por: Boyko, Yaryna, et al.
Publicado: (2020)

Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Is it worth allowing the presence of morning stiffness in the definition of inactive disease in juvenile idiopathic arthritis?
por: Allegra, Maddalena, et al.
Publicado: (2014)

Vaccinations Do Not Increase Arthritis Flares in Juvenile Idiopathic Arthritis: A Study of the Relationship between Routine Childhood Vaccinations on the Australian Immunisation Schedule and Arthritis Activity in Children with Juvenile Idiopathic Arthritis
por: Alfayadh, Naba M., et al.
Publicado: (2020)

Articular Doppler ultrasonography in juvenile idiopathic arthritis in remission: a prospective study
por: Terreri, Maria Teresa, et al.
Publicado: (2011)

Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission
por: Aranda-Valera, Inmaculada Concepción, et al.
Publicado: (2020)

Polyarticular juvenile idiopathic arthritis (pJIA): clinical and serologic predictors of inactive disease (ID)
por: Meiorin, Silvia
Publicado: (2014)

Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritis
por: Hügle, Boris, et al.
Publicado: (2018)

Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab
por: Horneff, Gerd, et al.
Publicado: (2016)

Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry
por: Hahn, Timothy, et al.
Publicado: (2022)

Predictive Value of Magnetic Resonance Imaging in Patients With Juvenile Idiopathic Arthritis in Clinical Remission
por: Mazzoni, Marta, et al.
Publicado: (2022)

Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_grk9mfjrkr6mv2gok92igciff0